Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents

Mayo Clinic Proceedings

Volumn 75, Issue 6, 2000, Pages 643-645

  Dellaripa, Paul F ^a   Wechsler, Michael E ^b   Roth, Monique E ^c   Drazen, Jeffrey ^d,e  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; ZAFIRLUKAST; ZILEUTON;

ADULT; ARTICLE; ASTHMA; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; ERYTHEMA NODOSUM; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MALE; NEUROLOGIC EXAMINATION; PANNICULITIS; PATHOGENESIS; SKIN MANIFESTATION;

EID: 0034043390     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.6.643     Document Type: Article

References (8)

1. McNutt NS, Moreno A, Contreras F. Inflammatory diseases of the subcutaneous fat. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven; 1997:429-455.
2. Fish JE, Kemp JP, Lockey RF, Glass M, Hanby LA, Bonuccelli CM, Zafirlukast Trialists Group. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. Clin Ther. 1997;19:675-690.
3. US Food and Drug Administration, Division of Epidemiology and Surveillance Spontaneous Reporting System Database, 1998. Data obtained through Freedom of Information Act.
4. US Food and Drug Administration Medical Products Reporting Program, Report 2085342, September 25,1997. Report obtained through Freedom of Information Act.
5. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving Zafirlukast. JAMA. 1998; 279:455-457.
6. Davis MD, Daoud MS, McEvoy MT, Su WP. Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol. 1997;37:199-203.
7. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-1100.
8. Bondi EE, Margolis DJ, Lazarus GS. Disorders of subcutaneous tissue: panniculitis. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:1275-1289.